Wave Life Sciences Ltd

(NASDAQ:WVE)

Latest On Wave Life Sciences Ltd (WVE):

Date/Time Type Description Signal Details
2023-05-23 19:33 ESTNewsWave Life Sciences crashes on decision to drop neurology asset on trial setbackN/A
2023-05-03 17:10 ESTNewsWave Life Sciences GAAP EPS of -$0.27 misses by $0.23, revenue of $12.93M misses by $25.67MN/A
2023-05-03 17:10 ESTNewsWave Life Sciences Ltd. (WVE) Q1 2023 Earnings Call TranscriptN/A
2023-05-02 16:03 ESTNewsWave Life Sciences Q1 2023 Earnings PreviewN/A
2023-03-22 19:19 ESTNewsWave Life Sciences GAAP EPS of -$0.47 misses by $0.06, revenue of $1.24M misses by $1.16MN/A
2023-03-22 19:18 ESTNewsWave Life Sciences Ltd. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-03-22 19:18 ESTNewsWave Life Sciences Ltd (WVE) Q4 2022 Earnings Call TranscriptN/A
2023-03-21 11:59 ESTNewsWave Life Sciences Q4 2022 Earnings PreviewN/A
2023-03-13 05:38 ESTNewsRAPT Therapeutics, Repare Therapeutics among biotechs to disclose exposure to Silicon Valley BankN/A
2023-01-08 08:22 ESTNewsWave Life Sciences: Huntington's Hypotheses, GSK Collaboration Catalysts To Move The NeedleN/A
2022-12-13 14:27 ESTNewsWave Life stock surges 20% in team up with GSK for genetic diseasesN/A
2022-11-11 01:23 ESTNewsWave Life Sciences Ltd. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-11 01:23 ESTNewsWave Life Sciences Ltd. (WVE) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 07:50 ESTNewsWave Life Sciences GAAP EPS of -$0.42 beats by $0.08, revenue of $0.29M misses by $5.11MN/A
2022-11-09 14:49 ESTNewsWave Life Sciences Q3 2022 Earnings PreviewN/A
2022-09-21 00:13 ESTNewsWave Life's WVE-003 shows promise in interim data of Huntington's disease trialN/A
2022-08-11 17:59 ESTNewsWave Life Sciences GAAP EPS of -$0.62 misses by $0.08, revenue of $0.37MN/A
2022-08-11 17:59 ESTNewsWave Life Sciences Ltd. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-11 17:59 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 01:42 ESTNewsWave Life Sciences Q2 2022 Earnings PreviewN/A
2022-06-22 10:01 ESTNewsRa Capital Management raises passive stake in Wave Life SciencesN/A
2022-06-15 00:46 ESTNewsWave Life Sciences to raise $70M in stock offeringN/A
2022-05-14 05:36 ESTNewsWave Life Sciences Ltd.'s (WVE) CEO Paul Bolno on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-14 05:36 ESTNewsWave Life Sciences slips as H.C. Wainwright lowers targetN/A
2022-05-13 02:49 ESTNewsWave Life Sciences GAAP EPS of -$0.62 misses by $0.06, revenue of $1.75M misses by $2.11MN/A
2022-05-13 02:49 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-13 02:49 ESTNewsWave Life Sciences Ltd. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-12 06:46 ESTNewsWave Life Sciences Q1 2022 Earnings PreviewN/A
2022-04-05 01:08 ESTNewsWave Life gains most in more than a year after early-stage data for ALS drugN/A
2022-03-31 02:14 ESTNewsWave Life Sciences (WVE) Investor Presentation - SlideshowN/A
2022-03-05 07:12 ESTNewsWave Life Sciences Ltd. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-03 20:07 ESTNewsWave Life Sciences GAAP EPS of -$0.61 misses by $0.06, revenue of $1.76M misses by $11.98MN/A
2022-03-03 20:06 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-03 02:56 ESTNewsWave Life Sciences Q4 2021 Earnings PreviewN/A
2022-01-25 21:00 ESTNewsWave Life Sciences' FTD, ALS clinical program to get investment from 2 organizationsN/A
2021-11-10 18:38 ESTNewsWave Life Sciences EPS beats by $0.52, beats on revenueN/A
2021-11-10 18:37 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 18:37 ESTNewsWave Life Sciences Ltd. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-09 19:57 ESTNewsWave Life Sciences Q3 2021 Earnings PreviewN/A
2021-10-18 23:49 ESTNewsWave Life Sciences, Takeda amend CNS research collaborationN/A
2021-10-18 23:49 ESTNewsTakeda discontinues research with Wave for certain CNS programs; Wave to get $22.5MN/A
2021-09-30 02:27 ESTNewsDosing underway in Wave Life's mid-stage WVE-N531 study in Duchenne muscular dystrophyN/A
2021-09-29 03:19 ESTNewsWave Life Sciences falls after presentation on its RNA editing capability (Updated)N/A
2021-09-09 14:39 ESTNewsWave Life Sciences gets dosing underway in early-stage Huntington’s disease trialN/A
2021-08-17 03:33 ESTNewsWave Life Sciences Ltd. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-08 22:24 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-05 16:13 ESTNewsWave Life Sciences EPS misses by $0.14, misses on revenueN/A
2021-07-22 09:27 ESTNewsWave Life Sciences posts proof-of-concept data from genetic disorder studyN/A
2021-07-22 08:54 ESTNewsDosing underway in Wave Life Sciences' mid-stage WVE-004 study in neurodegenerative diseasesN/A
2021-03-29 20:19 ESTNewsWave Life Sciences falls on setback for Huntington’s disease trial (updated)N/A

About Wave Life Sciences Ltd (WVE):

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It develops WVE-120101 and WVE-120102, a stereopure therapeutic candidates, which are in Phase 1b/2a clinical trials for the treatment of Huntington's disease (HD); WVE-003, mutant huntingtin SNP3 program for the treatment of HD; WVE-004, C9orf72 program for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-N531, our Exon 53 program for the treatment of Duchenne muscular dystrophy; and ATXN3 program in SCA3. The company has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, and University of Massachusetts. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

See Advanced Chart

General

  • Name Wave Life Sciences Ltd
  • Symbol WVE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 217
  • Fiscal Year EndDecember
  • IPO Date2015-11-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.wavelifesciences.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 17.92
  • Price/Book (Most Recent Quarter) 5.85
  • Enterprise Value Revenue 16.38
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.80
  • Next Year EPS Estimate -$2.16
  • Next Quarter EPS Estimate -$0.53
  • Operating Margin -764%
  • Return on Assets -34%
  • Return on Equity -185%
  • Revenue 20.08 million
  • Earnings Per Share -$5.15
  • Revenue Per Share $0.51
  • Gross Profit -110867000
  • Quarterly Earnings Growth 293.3%
View More

Highlights

  • Market Capitalization 486.05 million
  • EBITDA -173971008
  • PE Ratio -9.74
  • Analyst Target Price $16.86
  • Book Value Per Share $1.70
View More

Share Statistics

  • Shares Outstanding 49 million
  • Shares Float 31.16 million
  • % Held by Insiders 1297%
  • % Held by Institutions 76.71%
  • Shares Short 4.92 million
  • Shares Short Prior Month 4.38 million
  • Short Ratio 9.71
  • Short % of Float 13%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 0.37
  • 52 Week High $19.98
  • 52 Week Low $6.76
  • 50 Day Moving Average 10.18
  • 200 Day Moving Average 9.71
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Wave Life Sciences Ltd (WVE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Wave Life Sciences Ltd (WVE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-04$9.44 million-$0.59-$0.602.14%
2020-09-302020-11-09$N/A-$0.86-$0.73-17.81%
2020-06-302020-08-10$N/A-$1.15-$1.07-7.48%
2020-03-312020-05-11$4.16 million-$1.38-$1.32-4.41%
2019-12-312020-03-02$2.4 million-$1.65-$1.46-13.35%
2019-09-302019-11-05$2.93 million-$1.48-$1.37-8.37%
2019-06-302019-07-29$7.63 million-$1.22-$1.00-22.31%
2019-03-312019-05-10$3.03 million-$1.36-$1.20-13.1%
2018-12-312019-03-01$3.62 million-$1.28-$1.25-2.81%
2018-09-302018-11-09$4.49 million-$1.28-$1.24-2.89%
2018-06-302018-08-09$4.88 million-$1.23-$1.10-11.56%
2018-03-312018-05-09$1.42 million-$1.26-$0.91-38.97%
2017-12-312018-03-12$1.68 million-$1.10-$1.04-5.43%
2017-09-302017-11-09$1.32 million-$0.94-$0.984.08%
2017-06-302017-08-09$1.1 million-$0.92-$0.81-13.23%
2017-03-312017-05-10$383000-$0.89-$0.76-17.49%
2016-12-312017-03-16$676000-$0.81-$0.67-20.45%
2016-09-302016-11-09$392000-$0.75-$0.53-41.51%
2016-06-302016-08-15$417000-$0.51-$0.37-37.84%
2016-03-312016-05-16$N/A-$0.36-$0.396.9%
2015-12-312016-03-30$N/A-$0.47-$0.32-46.88%
2015-09-302015-11-11$26000-$0.54-$0.29-86.21%

Wave Life Sciences Ltd (WVE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Wave Life Sciences Ltd (WVE) Chart:

Wave Life Sciences Ltd (WVE) News:

Below you will find a list of latest news for Wave Life Sciences Ltd (WVE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Wave Life Sciences Ltd (WVE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-1530CALL0 0669.06TRUE00
2026-05-1540CALL0 5569.32TRUE00
2026-05-1552.25CALL0 38172.11TRUE00
2026-05-1561.25CALL0 379207.47TRUE00
2026-05-1570.19CALL528 1838113.1FALSE-0.11-0.37
2026-05-1580.06CALL1 1209153.27FALSE0.010.2
2026-05-1590.06CALL0 215237.37FALSE00
2026-05-15100CALL0 72319.5FALSE00
2026-05-15110CALL0 6550.11FALSE00
2026-05-15120CALL0 6532.32FALSE00
2026-05-15130CALL0 203578.65FALSE00
2026-05-15140CALL0 342668.03FALSE00
2026-05-15150.03CALL0 272417.87FALSE00
2026-05-15160CALL0 0772.88FALSE00
2026-05-15170CALL0 2805.95FALSE00
2026-05-15180CALL0 0836.54FALSE00
2026-05-15190CALL0 0864.97FALSE00
2026-05-15200CALL0 1859.13FALSE00
2026-05-15210CALL0 0883.68FALSE00
2026-05-1530PUT0 0488.5FALSE00
2026-05-1540PUT0 0709.45FALSE00
2026-05-1550PUT0 105412.08FALSE00
2026-05-1560PUT0 10331124.86FALSE00
2026-05-1570.3PUT122 90270.89TRUE0.10.5
2026-05-1581.2PUT10 1390TRUE0.30.33
2026-05-1590PUT0 1530TRUE00
2026-05-15100PUT0 10TRUE00
2026-05-15110PUT0 00TRUE00
2026-05-15120PUT0 00TRUE00
2026-05-15130PUT0 00TRUE00
2026-05-15140PUT0 00TRUE00
2026-05-15150PUT0 00TRUE00
2026-05-15160PUT0 00TRUE00
2026-05-15170PUT0 00TRUE00
2026-05-15180PUT0 00TRUE00
2026-05-15190PUT0 00TRUE00
2026-05-15200PUT0 00TRUE00
2026-05-15210PUT0 00TRUE00
2026-06-1810CALL0 0598.1TRUE00
2026-06-1820CALL0 0393.02TRUE00
2026-06-1830CALL0 0384.98TRUE00
2026-06-1840CALL0 0128.55TRUE00
2026-06-1852.2CALL30 10144.04TRUE2.20
2026-06-1860CALL0 13139.76TRUE00
2026-06-1870.85CALL19 581107.98FALSE-0.15-0.15
2026-06-1880.51CALL585 11282106.37FALSE-0.04-0.07
2026-06-1890.45CALL0 138139.16FALSE00
2026-06-18100.28CALL0 395110.4FALSE00
2026-06-18110.35CALL0 18122.28FALSE00
2026-06-18120CALL0 0171.74FALSE00
2026-06-18130CALL0 0173.18FALSE00
2026-06-18140CALL0 0171.15FALSE00
2026-06-18150.13CALL0 1158.26FALSE00
2026-06-1810PUT0 1314.36FALSE00
2026-06-1820PUT0 0202.32FALSE00
2026-06-1830PUT0 0139.59FALSE00
2026-06-1840PUT0 0173.44FALSE00
2026-06-1850.2PUT1 14108.18FALSE0.20
2026-06-1860.45PUT33 11397.91FALSE0.10.29
2026-06-1870.85PUT52 46186.34TRUE0.850
2026-06-1881.65PUT4 387100.96TRUE1.650
2026-06-1890PUT0 0108.31TRUE00
2026-06-18100PUT0 2151.09TRUE00
2026-06-18110PUT0 20TRUE00
2026-06-18120PUT0 00TRUE00
2026-06-18130PUT0 00TRUE00
2026-06-18140PUT0 00TRUE00
2026-06-18150PUT0 00TRUE00
2026-07-1710CALL0 0476.61TRUE00
2026-07-1720CALL0 30268.64TRUE00
2026-07-1730CALL0 0236.92TRUE00
2026-07-1740CALL0 0106.32TRUE00
2026-07-1752.6CALL0 125103.24TRUE00
2026-07-1761.7CALL10 209116.11TRUE-0.3-0.15
2026-07-1771CALL9 91493.25FALSE10
2026-07-1780.65CALL9 185091.65FALSE-0.15-0.19
2026-07-1790.55CALL0 36484.09FALSE00
2026-07-17100.3CALL5 40094.48FALSE0.30
2026-07-17110.2CALL0 870113.58FALSE00
2026-07-17120.23CALL0 7597.85FALSE00
2026-07-17130CALL0 188144.44FALSE00
2026-07-17140CALL0 327131.48FALSE00
2026-07-17150.08CALL8 705107.84FALSE0.080
2026-07-17160CALL0 97150.55FALSE00
2026-07-17170CALL0 20145.55FALSE00
2026-07-17180.05CALL0 161174.32FALSE00
2026-07-17190CALL0 90142.47FALSE00
2026-07-17200.06CALL0 136189.38FALSE00
2026-07-17210CALL0 20172.08FALSE00
2026-07-17220CALL0 1199.71FALSE00
2026-07-17230CALL0 4176.8FALSE00
2026-07-17240.05CALL0 19176.13FALSE00
2026-07-17250.05CALL10 344145.21FALSE0.050
2026-07-17260CALL0 238188.83FALSE00
2026-07-17270CALL0 1197.17FALSE00
2026-07-17280CALL0 17228.25FALSE00
2026-07-17290CALL0 2241.85FALSE00
2026-07-17300CALL0 13245.3FALSE00
2026-07-17310CALL0 11248.61FALSE00
2026-07-17320CALL0 191251.79FALSE00
2026-07-17330CALL0 9254.86FALSE00
2026-07-17340CALL0 1257.81FALSE00
2026-07-17350CALL0 127260.66FALSE00
2026-07-1710PUT0 0293.17FALSE00
2026-07-1720PUT0 11151.8FALSE00
2026-07-1730PUT0 0156.49FALSE00
2026-07-1740PUT0 5152.43FALSE00
2026-07-1750PUT0 171102.84FALSE00
2026-07-1760.5PUT0 35196.54FALSE00
2026-07-1770PUT0 28482.95TRUE00
2026-07-1780PUT0 27462.7TRUE00
2026-07-1790PUT0 2282.76TRUE00
2026-07-17100PUT0 11176.83TRUE00
2026-07-17114PUT0 1370TRUE00
2026-07-17120PUT0 1410TRUE00
2026-07-17130PUT0 540TRUE00
2026-07-17140PUT0 150TRUE00
2026-07-17150PUT0 1350TRUE00
2026-07-17160PUT0 30TRUE00
2026-07-17170PUT0 00TRUE00
2026-07-17180PUT0 00TRUE00
2026-07-17190PUT0 00TRUE00
2026-07-17200PUT0 00TRUE00
2026-07-17210PUT0 00TRUE00
2026-07-17220PUT0 00TRUE00
2026-07-17230PUT0 00TRUE00
2026-07-17240PUT0 00TRUE00
2026-07-17250PUT0 00TRUE00
2026-07-17260PUT0 00TRUE00
2026-07-17270PUT0 00TRUE00
2026-07-17280PUT0 00TRUE00
2026-07-17290PUT0 0224.03TRUE00
2026-07-17300PUT0 00TRUE00
2026-07-17310PUT0 00TRUE00
2026-07-17320PUT0 00TRUE00
2026-07-17330PUT0 00TRUE00
2026-07-17340PUT0 00TRUE00
2026-07-17350PUT0 00TRUE00
2026-10-1630CALL0 5104.93TRUE00
2026-10-1640CALL0 097.04TRUE00
2026-10-1650CALL0 193.35TRUE00
2026-10-1662.25CALL0 3096.15TRUE00
2026-10-1672.08CALL0 2487.78FALSE00
2026-10-1681.4CALL0 4687.95FALSE00
2026-10-1690.96CALL1 590.2FALSE0.160.2
2026-10-16100.75CALL0 2291.01FALSE00
2026-10-16110.75CALL0 088.2FALSE00
2026-10-16120.55CALL0 72118.02FALSE00
2026-10-16130CALL0 5398.26FALSE00
2026-10-16140.45CALL0 4100.89FALSE00
2026-10-16150CALL0 13115.5FALSE00
2026-10-16160CALL0 0120.73FALSE00
2026-10-16170CALL0 5175.29FALSE00
2026-10-16180CALL0 3180.03FALSE00
2026-10-16190CALL0 2154.34FALSE00
2026-10-16200CALL0 6188.53FALSE00
2026-10-16210CALL0 1162.06FALSE00
2026-10-16250CALL0 65159.57FALSE00
2026-10-1630PUT0 0166.1FALSE00
2026-10-1640PUT0 0120.88FALSE00
2026-10-1650PUT0 12282.51FALSE00
2026-10-1660.87PUT0 1980.15FALSE00
2026-10-1671.3PUT0 11381.34TRUE00
2026-10-1680PUT0 676.59TRUE00
2026-10-1690PUT0 381.37TRUE00
2026-10-16100PUT0 11102.19TRUE00
2026-10-16110PUT0 277.32TRUE00
2026-10-16120PUT0 3367.69TRUE00
2026-10-16130PUT0 267.66TRUE00
2026-10-16140PUT0 00TRUE00
2026-10-16150PUT0 00TRUE00
2026-10-16160PUT0 00TRUE00
2026-10-16170PUT0 00TRUE00
2026-10-16180PUT0 00TRUE00
2026-10-16190PUT0 00TRUE00
2026-10-16200PUT0 00TRUE00
2026-10-16210PUT0 00TRUE00
2026-10-16250PUT0 00TRUE00
2026-12-1830CALL0 350TRUE00
2026-12-1840CALL0 0107.15TRUE00
2026-12-1850CALL0 160102.58TRUE00
2026-12-1860CALL0 299.7TRUE00
2026-12-1872CALL0 52102.19FALSE00
2026-12-1880CALL0 3287.9FALSE00
2026-12-1891.34CALL0 5104.88FALSE00
2026-12-18101.05CALL0 488102.96FALSE00
2026-12-18110CALL0 393.25FALSE00
2026-12-18120.95CALL0 17294.11FALSE00
2026-12-18130CALL0 099.06FALSE00
2026-12-18140CALL0 4100.61FALSE00
2026-12-18150.45CALL8 75189.51FALSE-0.02-0.04
2026-12-18160CALL0 0101.54FALSE00
2026-12-18170CALL0 87101FALSE00
2026-12-18180CALL0 54203.1FALSE00
2026-12-18200.25CALL1 21692.83FALSE0.250
2026-12-18220CALL0 61139.45FALSE00
2026-12-18250CALL0 133169.6FALSE00
2026-12-18270CALL0 1152.09FALSE00
2026-12-18300CALL0 95158.33FALSE00
2026-12-18320CALL0 2151.83FALSE00
2026-12-18350CALL0 218167.19FALSE00
2026-12-1830PUT0 0152.23FALSE00
2026-12-1840PUT0 0127.93FALSE00
2026-12-1850PUT0 5395.59FALSE00
2026-12-1860PUT0 282.32FALSE00
2026-12-1870PUT0 11458.82TRUE00
2026-12-1880PUT0 179.16TRUE00
2026-12-1890PUT0 070.31TRUE00
2026-12-18100PUT0 6580.68TRUE00
2026-12-18110PUT0 273.44TRUE00
2026-12-18120PUT0 1480.83TRUE00
2026-12-18130PUT0 277.82TRUE00
2026-12-18140PUT0 075.93TRUE00
2026-12-18150PUT0 570TRUE00
2026-12-18160PUT0 10TRUE00
2026-12-18170PUT0 00TRUE00
2026-12-18180PUT0 389.32TRUE00
2026-12-18200PUT0 10106.25TRUE00
2026-12-18220PUT0 20TRUE00
2026-12-18250PUT0 4112.29TRUE00
2026-12-18270PUT0 10TRUE00
2026-12-18300PUT0 00TRUE00
2026-12-18320PUT0 00TRUE00
2026-12-18350PUT0 00TRUE00
2027-01-1534.8CALL0 2687.59TRUE00
2027-01-1540CALL0 0100.38TRUE00
2027-01-1550CALL0 25888.37TRUE00
2027-01-1562.76CALL0 196.18TRUE00
2027-01-1570CALL0 095.92FALSE00
2027-01-1581.75CALL0 2491.58FALSE00
2027-01-1590CALL0 089.54FALSE00
2027-01-15101.1CALL22 147186.59FALSE1.10
2027-01-15110CALL0 091.06FALSE00
2027-01-15120.95CALL0 2979.79FALSE00
2027-01-15150CALL0 294FALSE00
2027-01-15170CALL0 394.96FALSE00
2027-01-15200.4CALL0 28596.64FALSE00
2027-01-15220CALL0 3114.77FALSE00
2027-01-1530PUT0 0133.23FALSE00
2027-01-1540PUT0 684.74FALSE00
2027-01-1550.65PUT0 1084.15FALSE00
2027-01-1560PUT0 075.33FALSE00
2027-01-1570PUT0 6076.67TRUE00
2027-01-1580PUT0 7068.34TRUE00
2027-01-1590PUT0 071.45TRUE00
2027-01-15100PUT0 071.92TRUE00
2027-01-15110PUT0 075.22TRUE00
2027-01-15120PUT0 071.29TRUE00
2027-01-15150PUT0 00TRUE00
2027-01-15170PUT0 075.92TRUE00
2027-01-15200PUT0 00TRUE00
2027-01-15220PUT0 00TRUE00
2027-06-1730CALL0 90107.94TRUE00
2027-06-1753.6CALL0 279132.92TRUE00
2027-06-1782.3CALL0 6580.75FALSE00
2027-06-17100CALL0 0117.14FALSE00
2027-06-17120CALL0 20128.66FALSE00
2027-06-17150CALL0 1087.91FALSE00
2027-06-17170CALL0 0148.29FALSE00
2027-06-17200CALL0 0156.66FALSE00
2027-06-17220CALL0 0161.38FALSE00
2027-06-1730PUT0 0318.41FALSE00
2027-06-1750PUT0 1156.55FALSE00
2027-06-1780PUT0 984.76TRUE00
2027-06-17100PUT0 084.84TRUE00
2027-06-17120PUT0 080.01TRUE00
2027-06-17150PUT0 073.84TRUE00
2027-06-17170PUT0 081.5TRUE00
2027-06-17200PUT0 091.24TRUE00
2027-06-17220PUT0 096.9TRUE00
2028-01-2134.8CALL23 239104.99TRUE4.80
2028-01-2154CALL0 14581.77TRUE00
2028-01-2183CALL0 117113.2FALSE00
2028-01-21102.3CALL20 3687.15FALSE-0.2-0.08
2028-01-21120CALL0 10103.21FALSE00
2028-01-21150CALL0 069.78FALSE00
2028-01-21170CALL0 0112.64FALSE00
2028-01-21200CALL0 4125.2FALSE00
2028-01-21220CALL0 1186.36FALSE00
2028-01-2130PUT0 2100.56FALSE00
2028-01-2150PUT0 4662.08FALSE00
2028-01-2180PUT0 270.85TRUE00
2028-01-21100PUT0 071.45TRUE00
2028-01-21120PUT0 082.82TRUE00
2028-01-21150PUT0 5080.94TRUE00
2028-01-21170PUT0 070.57TRUE00
2028-01-21200PUT0 079.11TRUE00
2028-01-21220PUT0 084.12TRUE00

Latest WVE Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST100$2
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST100$1.995

Wave Life Sciences Ltd (WVE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2019-08-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019012261/0000000000-19-012261-index.htm
2019-11-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019015921/0000000000-19-015921-index.htm
2019-12-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019016177/0000000000-19-016177-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000008025519002715/0000080255-19-002715-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000008025520001311/0000080255-20-001311-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000021545719006909/0000215457-19-006909-index.htm
2019-03-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000021545719007594/0000215457-19-007594-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000083423720008192/0000834237-20-008192-index.htm
2020-08-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000089542120000470/0000895421-20-000470-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318022514/0000899243-18-022514-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318022515/0000899243-18-022515-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-11-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004460/0000899243-19-004460-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004462/0000899243-19-004462-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004466/0000899243-19-004466-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004467/0000899243-19-004467-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007106/0000899243-19-007106-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007110/0000899243-19-007110-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007112/0000899243-19-007112-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007114/0000899243-19-007114-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021292/0000899243-19-021292-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021959/0000899243-19-021959-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021962/0000899243-19-021962-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021963/0000899243-19-021963-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021965/0000899243-19-021965-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021966/0000899243-19-021966-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021967/0000899243-19-021967-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023028/0000899243-19-023028-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023032/0000899243-19-023032-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023033/0000899243-19-023033-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023034/0000899243-19-023034-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023035/0000899243-19-023035-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023038/0000899243-19-023038-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2020-01-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320001393/0000899243-20-001393-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320003379/0000899243-20-003379-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005342/0000899243-20-005342-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005346/0000899243-20-005346-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005349/0000899243-20-005349-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005351/0000899243-20-005351-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007277/0000899243-20-007277-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007281/0000899243-20-007281-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007282/0000899243-20-007282-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007284/0000899243-20-007284-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007285/0000899243-20-007285-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023078/0000899243-20-023078-index.htm
2020-08-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023079/0000899243-20-023079-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023080/0000899243-20-023080-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023085/0000899243-20-023085-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023086/0000899243-20-023086-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023087/0000899243-20-023087-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023088/0000899243-20-023088-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023089/0000899243-20-023089-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023092/0000899243-20-023092-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023093/0000899243-20-023093-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2020-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000090221920000204/0000902219-20-000204-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000110465920021834/0001104659-20-021834-index.htm
2019-01-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000114420419003157/0001144204-19-003157-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000114420419003160/0001144204-19-003160-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000114420419008078/0001144204-19-008078-index.htm
2018-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518270464/0001193125-18-270464-index.htm
2018-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518290300/0001193125-18-290300-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518291962/0001193125-18-291962-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518295345/0001193125-18-295345-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518323137/0001193125-18-323137-index.htm
2018-11-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312518323760/0001193125-18-323760-index.htm
2018-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518342992/0001193125-18-342992-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519001144/0001193125-19-001144-index.htm
2019-01-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312519014851/0001193125-19-014851-index.htm
2019-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519014884/0001193125-19-014884-index.htm
2019-01-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312519015961/0001193125-19-015961-index.htm
2019-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519015976/0001193125-19-015976-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519040844/0001193125-19-040844-index.htm
2019-02-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000119312519045277/0001193125-19-045277-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519059251/0001193125-19-059251-index.htm
2019-03-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000119312519074933/0001193125-19-074933-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519107259/0001193125-19-107259-index.htm
2019-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000119312519125660/0001193125-19-125660-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519143674/0001193125-19-143674-index.htm
2019-05-10S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1631574/000119312519144278/0001193125-19-144278-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519165571/0001193125-19-165571-index.htm
2019-06-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519182697/0001193125-19-182697-index.htm
2019-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519205421/0001193125-19-205421-index.htm
2019-08-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1631574/000119312519214152/0001193125-19-214152-index.htm
2019-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519214169/0001193125-19-214169-index.htm
2019-08-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1631574/000119312519218981/0001193125-19-218981-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519221246/0001193125-19-221246-index.htm
2019-08-168-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519223468/0001193125-19-223468-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519238229/0001193125-19-238229-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519263797/0001193125-19-263797-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519284729/0001193125-19-284729-index.htm
2019-11-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519284817/0001193125-19-284817-index.htm
2019-12-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1631574/000119312519304738/0001193125-19-304738-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519314469/0001193125-19-314469-index.htm
2019-12-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519322733/0001193125-19-322733-index.htm
2019-12-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519325442/0001193125-19-325442-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520005483/0001193125-20-005483-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520005882/0001193125-20-005882-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520026760/0001193125-20-026760-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520037841/0001193125-20-037841-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520038291/0001193125-20-038291-index.htm
2020-03-02POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057766/0001193125-20-057766-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057791/0001193125-20-057791-index.htm
2020-03-02POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057905/0001193125-20-057905-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520107212/0001193125-20-107212-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520117339/0001193125-20-117339-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520138276/0001193125-20-138276-index.htm
2020-06-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520181069/0001193125-20-181069-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214106/0001193125-20-214106-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214144/0001193125-20-214144-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214223/0001193125-20-214223-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520223731/0001193125-20-223731-index.htm
2020-08-198-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520224764/0001193125-20-224764-index.htm
2020-08-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520229903/0001193125-20-229903-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520241608/0001193125-20-241608-index.htm
2020-09-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312520251261/0001193125-20-251261-index.htm
2020-09-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520251297/0001193125-20-251297-index.htm
2020-09-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312520252307/0001193125-20-252307-index.htm
2020-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520252347/0001193125-20-252347-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520254552/0001193125-20-254552-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520260543/0001193125-20-260543-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417319000113/0001274173-19-000113-index.htm
2019-08-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417319000120/0001274173-19-000120-index.htm
2020-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417320000004/0001274173-20-000004-index.htm
2020-01-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000149315220000835/0001493152-20-000835-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459018028757/0001564590-18-028757-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459019005671/0001564590-19-005671-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019018521/0001564590-19-018521-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019029396/0001564590-19-029396-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019040431/0001564590-19-040431-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/0001564590-20-007972-index.htm
2020-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459020019772/0001564590-20-019772-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459020023860/0001564590-20-023860-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459020038620/0001564590-20-038620-index.htm
2019-08-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1631574/999999999519001883/9999999995-19-001883-index.htm
2020-05-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1631574/999999999520000974/9999999995-20-000974-index.htm
2018-09-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1631574/999999999718007937/9999999997-18-007937-index.htm

Wave Life Sciences Ltd (WVE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Wave Life Sciences Ltd (WVE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1297%
Institutional Ownership: 7671%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-19Keith RegnanteChief Financial OfficerSell1,298.0036.8447,817.8015,686.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004467/0000899243-19-004467-index.htm
2018-09-24Keith RegnanteChief Financial OfficerSell29,500.0055.001,622,500.0016,984.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2019-02-19Chris FrancisOfficerSell1,709.0036.8462,959.0520,368.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004460/0000899243-19-004460-index.htm
2018-09-24Chris FrancisOfficerSell1,032.0056.0057,792.0022,077.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-09-25Chris FrancisOfficerSell10,543.0056.00590,408.0022,077.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-09-24Chris FrancisOfficerBuy1,032.002.482,559.3623,109.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2019-02-19Chandra VargeeseSenior VP, Drug DiscoverySell2,055.0036.8475,706.2025,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004462/0000899243-19-004462-index.htm
2019-02-19PAUL BOLNOPresident and CEOSell119.0037.474,458.45271,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2019-02-19PAUL BOLNOPresident and CEOSell7,614.0036.38276,997.32271,328.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell43,068.0010.26441,877.68272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell95,921.0010.27985,108.67272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-08-25PAUL BOLNOPresident and CEOSell25,000.0012.00300,000.00272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2020-09-15PAUL BOLNOPresident and CEOSell100,000.0015.001,500,000.00272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2018-09-24Chandra VargeeseSenior VP, Drug DiscoverySell3,000.0055.00165,000.0027,300.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2019-03-07Keith RegnanteChief Financial OfficerBuy13,500.0029,186.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007114/0000899243-19-007114-index.htm
2020-08-25PAUL BOLNOPresident and CEOBuy25,000.002.4862,000.00297,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2019-11-20Gregory L. VerdineDirectorSell2,609.0032.7485,418.6630,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2018-09-24Chandra VargeeseSenior VP, Drug DiscoveryBuy3,000.002.487,440.0030,300.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2020-02-18Chris FrancisOfficerSell2,708.007.8521,257.8031,160.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005346/0000899243-20-005346-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell4,509.0010.8248,787.38315,249.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-02-18PAUL BOLNOPresident and CEOSell11,451.007.8589,890.35319,758.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005349/0000899243-20-005349-index.htm
2019-11-20Gregory L. VerdineDirectorSell3,400.0031.59107,406.0032,609.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2018-09-25Chris FrancisOfficerBuy10,543.002.4826,146.6432,620.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2019-03-07PAUL BOLNOPresident and CEOBuy60,000.00331,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007112/0000899243-19-007112-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell1,763.0046.0081,098.00331,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell8,237.0045.22372,477.14332,972.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-07Chris FrancisOfficerBuy13,500.0033,868.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007110/0000899243-19-007110-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell5,065.0045.89232,432.85341,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell34,935.0045.451,587,795.75346,274.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-08-05Mark BaldryChief Commerical OfficerBuy35,000.0035,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2019-11-20Gregory L. VerdineDirectorSell24,030.0030.27727,388.1036,009.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell4,079.0010.9144,501.89368,102.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-02-18Chandra VargeeseSenior VP, Drug DiscoverySell3,188.007.8525,025.8037,057.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005342/0000899243-20-005342-index.htm
2020-07-02PAUL BOLNOPresident and CEOBuy100,000.002.48248,000.00372,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-09-15PAUL BOLNOPresident and CEOBuy100,000.002.48248,000.00372,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2019-02-19Michael A. PanzaraFranchise Lead, NeurologySell1,837.0036.8467,673.9837,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004466/0000899243-19-004466-index.htm
2019-03-15PAUL BOLNOPresident and CEOBuy50,000.002.48124,000.00381,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-08-05Mark BaldryChief Commerical OfficerBuy4,000.0039,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2020-02-18Michael A. PanzaraChief Medical OfficerSell2,981.007.8523,400.8539,349.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005351/0000899243-20-005351-index.htm
2019-03-07Chandra VargeeseSenior VP, Drug DiscoveryBuy15,000.0040,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007106/0000899243-19-007106-index.htm
2019-12-03Chandra VargeeseSenior VP, Drug DiscoverySell6,000.0035.00210,000.0040,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2019-07-05Michael A. PanzaraChief Medical OfficerSell445.0027.2612,130.7042,330.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-07-05Michael A. PanzaraChief Medical OfficerSell2,613.0026.8870,237.4442,775.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-03-11Michael A. PanzaraFranchise Lead, NeurologySell7,000.0048.00336,000.0045,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2019-12-03Chandra VargeeseSenior VP, Drug DiscoveryBuy6,000.002.4814,880.0046,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2018-09-24Keith RegnanteChief Financial OfficerBuy29,500.0020.89616,255.0046,484.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2019-03-07Michael A. PanzaraFranchise Lead, NeurologyBuy15,000.0052,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2018-11-14Gregory L. VerdineDirectorSell4,300.0039.52169,936.0060,039.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2020-02-03David G GaieroInterim CFOSell651.007.004,557.006,392.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320003379/0000899243-20-003379-index.htm
2018-11-14Gregory L. VerdineDirectorSell10,700.0038.59412,913.0064,339.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2019-01-24RA CAPITAL MANAGEMENT, LLCDirectorBuy263,158.0038.0010,000,004.007,775,207.00https://www.sec.gov/Archives/edgar/data/1631574/000114420419003160/0001144204-19-003160-index.htm